PDF herunterladen
Thromb Haemost 2006; 96(05): 692-694
DOI: 10.1160/TH06-04-0206
Letters to the Editor
Schattauer GmbH

Characterization of an acquired factor VIII inhibitor and plasmapheresis therapy in a patient with bullous pemphigoid

Guang-Sen Zhang
1   Division of Hematology, Institute of Molecular Hematology, the Second Xiang-Ya Hospital, Central South University, Chang Sha, Hunan, P. R. China
,
Wen-Li Zuo
1   Division of Hematology, Institute of Molecular Hematology, the Second Xiang-Ya Hospital, Central South University, Chang Sha, Hunan, P. R. China
,
Chong-Wen Dai
1   Division of Hematology, Institute of Molecular Hematology, the Second Xiang-Ya Hospital, Central South University, Chang Sha, Hunan, P. R. China
,
Yun-Xiao Xu
1   Division of Hematology, Institute of Molecular Hematology, the Second Xiang-Ya Hospital, Central South University, Chang Sha, Hunan, P. R. China
,
Jian-Kai Shen
1   Division of Hematology, Institute of Molecular Hematology, the Second Xiang-Ya Hospital, Central South University, Chang Sha, Hunan, P. R. China
,
Yun-Ya Luo
1   Division of Hematology, Institute of Molecular Hematology, the Second Xiang-Ya Hospital, Central South University, Chang Sha, Hunan, P. R. China
,
Yan Yi
1   Division of Hematology, Institute of Molecular Hematology, the Second Xiang-Ya Hospital, Central South University, Chang Sha, Hunan, P. R. China
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 12. April 2006

Accepted after resubmission 08. September 2006

Publikationsdatum:
01. Dezember 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

 

 

  • References

  • 1 Lightburn E, Morand JJ, Graffin B. et al. Pemphigoid and acquired hemophilia. Ann Dermatol Venereol 2001; 128: 1229-31.
    PubMedGoogle Scholar
  • 2 Mac Zekc, Thoma-Uszynski S, Schuler G. et al. Simultaneous onset of pemphigoid and factor VIII antibody hemophilia. Hautarzt 2002; 53: 412-5.
    CrossrefPubMedGoogle Scholar
  • 3 Vissink A, van Coevorden AM, Spijkervet FK. et al. Spontaneous blood blister formation swelling of the oral mucosa. Ned Tijdschr Tandheelkd 2003; 110: 359-61.
    PubMedGoogle Scholar
  • 4 Patel RS, Harman KE, Nichols C. et al. Bullous pemphigoid and acquired hemophilia. Postgrad Med J 2006; 82: 3.
    CrossrefPubMedGoogle Scholar
  • 5 Kasper CK, Aledort LM, Counts RB. et al. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorr 1975; 34: 869-72.
    PubMedGoogle Scholar
  • 6 Fulcher CA, de Graaf Mahoney S, Roberts JR. et al. Localization of human factor VIII inhibitor epitopes to two polypeptide fragments. Proc Natl Acad Sci USA 1985; 82: 7728.
    CrossrefPubMedGoogle Scholar
  • 7 Spiegel Jr. PC, Stoddard BL. Optimization of factor VIII replacement therapy: can structural studies help in evading antibody inhibitors?. Brit J Haemotol 2002; 119: 310-22.
    PubMedGoogle Scholar
  • 8 Lavigne-Lissalde G, Schved JF, Granier C. et al. Anti-factor VIII antibodies, a 2005 update. Thromb Haemost 2005; 94: 760-9.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 9 Fay PS, Scandella D. Human inhibitor antibodies specific for the factor VIII A2 domain disrupt the interaction between the subunit and factor IXa. J Biol Chem 1999; 274: 29826-30.
    CrossrefPubMedGoogle Scholar
  • 10 Scandella D, DeGraaf Mahoney S, Mattingly M. et al. Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Eschericha coli . Proc Natl Acad Sci USA 1988; 85: 6152-6.
    CrossrefPubMedGoogle Scholar
  • 11 Lollar P, Parker WT, Fay PJ. Coagulant properties of hybrid human/porcine factor VIII molecules. J Biol Chem 1992; 267: 2362-7.
    PubMedGoogle Scholar
  • 12 Huang CC, Shen MC, Chen JY. et al. Epitope mapping of factor VIII inhibitor antibodies of Chinese origin. Brit J Haemotol 2001; 113: 915-24.
    PubMedGoogle Scholar